Health Archive » September, 2023

Health - September, 2023

469 articles

• Cigna To Pay $172M To End Medicare Advantage FCA Claims
• Idaho Can Enforce Abortion Ban During Appeal, 9th Circ. Says
• US Chamber Loses Bid To Stop Medicare Drug Price Talks
• Docs Say Maya Kowalski's Mom Didn't Set Off Alarm Bells
• Gilead Must Face HIV Drug Design-Defect Claims At Trial
• FDA Wants Oversight Of Lab-Developed Tests
• Ex-USPTO Head Says Breaking Patents Won't Cut Drug Prices
• Pro Say: A Cheat Sheet For The New Supreme Court Term
• Insurer Secures Win In Ga. Hospitals' COVID-19 Coverage Suit
• 6th Circ. Revives Bans On Gender-Affirming Care For Minors
• Notification Issue Can't Excuse Failure To Bid On VA Contract
• HHS Watchdog Says Pathology Deal Carries Kickback Risk
• Texas Justices To Hear UT Royalty Dispute With Pet Co.
• Atty Files FOIA Suit Over HHS Pot Recommendation Letter
• Hospice Head Gets 4 Years For $150M Medicare Billing Fraud
• Avoiding The Ethical Pitfalls Of Crowdfunded Legal Fees
• 'False' Info Led To Pfizer Insider Trading Case, Court Told
• Texas Firm Tells Appeals Court Anti-SLAPP Move Is Stall Effort
• 'Administrative State' Attacks Soar To High Court Crescendo
• Texas Mental Health Care Co.'s $2M Fraud Suit Sent To Conn.
• UK Litigation Roundup: Here's What You Missed In London
• NTIA Seeking Ideas For Protecting Minors Online
• 4 Pharma Industry Arguments Against CMS Drug Pricing Plan
• Ill. Hospitals, Doc Can't Escape Suit Over Patient's UTI Death
• 4 Argument Sessions ERISA Attys Should Watch In October
• First-Time Advocates Dominate High Court's Fall Schedule
• Taxation With Representation: Skadden, Ropes & Gray
• 5 Supreme Court Cases To Watch This Fall
• Cedars-Sinai Tells 9th Circ. Data Suit Belongs In Federal Court
• 3rd Circ. Skeptical Of NLRB Order For Nonprofit To Bargain
• State Farm Seeks End To $31M Medical Billing Settlement Row
• House Tax Panel Advances HSA Expansion Bills
• Opioid Special Master's Email Doesn't Betray Bias, Court Told
• Boehringer Bemoans Medicare Drug Price Talks As 'A Sham'
• Regeneron Wins Higher Bar At Trial For FCA Kickback Theory
• Ga. Sperm Bank Not Covered Over Donor Claims, Insurer Says
• Yelp, Paxton Start Fight Over Anti-Abortion Centers Disclaimer
• Ex-Health Care Co. Workers Preserve Bulk Of ERISA Case
• Federal Law Stops NC's Med Mal Time Bar, 4th Circ. Told
• Texas Appeals Court Upholds Temporary Block Of Delta-8 Ban
• Watchdog Questions Competition In $45M KPMG COVID Deal
• Mo. Patient Privacy Suit Doesn't Need Affidavit Of Merit
• Boston Hospital Can't Sink Employee Vax Case In One Shot
• Imerys Insurers Will Get Mediator For Ch. 11 Settlement Effort
• Deals Rumor Mill: Manchester U, Warriors, Citigroup China
• MSN Beats Allergan's Generic Patent Row In Bench Trial
• First Wave BioPharma Director Loses Legal Fee Battle In Del.
• Bradley Arant Adds Carlton Fields Health Care Counsel In DC
• Issues Ahead As Psychedelic Medicine Faces Pivotal Moment
• Ohio Justices Query State's Bid To Lift Block On Abortion Ban
• Monsanto Questions Relevance Of PCB Rat Research At Trial
• Court Finds La. Hospital Merger Exempt From FTC Review
• Sutter Health Nears Win In Physician's Suit Alleging Kickbacks
• 'Unreliable' Experts Sink $224M Talc Award, J&J Tells Court
• Iowa Man Says DHS Detained Him Over Fake Birth Certificate
• Noteholders, Shareholders Call Mallinckrodt Ch. 11 Plan Unfair
• Implant Co. Loses Appeal On FCA Misbranding Question
• SEC Prevails Over Prolific Trader In Unregistered Dealer Suit
• Mylan Dodges Contract Breach Claim In Takeda IP Fight
• Takeda Unit, Ex-Worker Resolve Bias And Retaliation Suit
• Suit Over $11M Okla. Pot Crop Raze Sent Back To State Court
• AstraZeneca Seeks Quick Win In Drug Price Negotiation Fight
• 7th Circ. Judge Unsure X-Ray Tech Was Fired For Complaint
• Avalyn Pharma Raises $175M In Series C Financing Round
• 3rd Circ. Rejects Bid To Keep Pa. Virus Death Suit Federal
• Doctor Entangled In NBA Insurance Fraud Pleads Guilty
• Class Claims Homeopathic Eye Products Being Sold Illegally
• Surgalign Gets Texas Judge's OK For Ch. 11 Plan
• Virgin Pulse To Merge With HealthComp In $3B Deal
• Bracing For Regulatory Delays As Shutdown Looms
• An Overview Of 6 PBM Bills Moving Through Congress
• McKinsey Strikes $230M Opioid Deal With Gov'ts And Schools
• Wash. Supreme Court Mulls If Hep C Alert Is Actionable
• GAO OKs VA Decision To Set Aside $99M Deal For Small Biz
• Insurer Says No Coverage For Health Software Cos.' BIPA Row
• Eyelid Wiper New Enough To Judge To Keep Patent Suit Alive
• Food 'Fraud' Can't Apply To Nursing Homes, NJ Justices Told
• Maya Kowalski Told Doc She Was Afraid Of Upsetting Mother
• Fla. Lab Owner Hit With $370M In Judgments For Bogus Billing
• Hospital Network Must Give Nurses Benefit Communications
• Axsome Beats Securities Suit Over Migraine Drug, For Now
• Ga. Health System Strikes Deal To Settle ERISA Class Action
• Hospital Freed From Mo. Man's Suit Over Wife's Sperm Swap
• Anti-Fraud Group Defends FCA's Whistleblower Provisions
• Amazon, Google Give Views On Counterfeit Goods
• Worker Tells 8th Circ. Class Participation Guarantees Tolling
• Wash. Justice Says Court Can't Be Jury In Liberty Mutual Row
• Judge Limits Flint Expert's Testimony On 'Community Trauma'
• Doctors Back 5th Circ. Bid To Nix 'No Surprises' Billing Reg
• Accounting Board Fines BDO $2M Over Missed Red Flags
• Miss. Orthopedic Group Sued For Patient Data Hack
• Enviro Groups Urge EPA To Regulate Rail Cars' Coal Pollution
• Sutter Health Bills Included Unnecessary Charges, Judge Told
• 3M And DuPont Want Ga. PFAS Pollution Suit Paused
• DOD Abortion Rules Don't Need Congress' Review, GAO Says
• 10th Circ. ERISA Ruling Is Promising For Self-Funded Plans
• Kodak Scores Exit From Investors' COVID Supply Deal Suit
• 3 Firms Build Alfasigma's Nearly $800M Intercept Pharma Buy
• Ind. Justices Revive Suit Against Hospital For Privacy Breach
• NC Lab Owner Gets Nearly 17 Years For Medicaid Fraud
• Judge OKs Fees For Talc Lawyers In J&J Unit's First Ch. 11
• Real Estate Rumors: KDM, Allen Morris, Argyle
• Jury Finds NC Doctor Lied In Medical Brace Authorizations
• Florida Man Admits To $16.7M HIV Drug Fraud Conspiracy
• Colo. Informs Pot Industry Of Next Steps For Rescheduling
• The 2023 Law360 Pulse Social Impact Leaders
• Why Law Firm ESG Is Likely Here To Stay
• What Large Language Models Mean For Document Review
• Orthopedic Center Escapes Hip Surgery Negligence Suit
• Husch Blackwell Adds Harris Bricken Cannabis Pro In LA
• HHS Seeks Fee Bumps For 'No Surprises Act' Arbitration
• PBM Group Must Respond To 10th Circ. En Banc Petition
• NY Hospital, Staffing Co. Can't Toss Pregnancy Bias Suit
• UAW, Health Fund Notch Settlement In Enrollment Fraud Row
• IBM, J&J Face Class Action Over August Patient Data Breach
• NC Doctor Loses Mistrial Bid As Jury Mulls $11M Fraud Case
• Sutter Health Judge Doubts Plaintiff's Expert In $519M Trial
• NC Abortion Law 'Irrational,' Federal Court Hears
• Target Must Face Bulk Of Suit Over 'Non-Drowsy' Flu Medicine
• 7th Circ. Backs Illinois Cannabis Dispensary License Rules
• NJ Health Care Co. Owes Ex-Execs Unpaid Wages, Court Told
• Statute Protects Humans, Not Hospice Co., Colo. Justices Say
• 3rd Circ. OKs Toss Of Bias Suit Over Threatening Messages
• Mich. Top Court To Weigh Lost Pay Damages For Children
• Checking In On How SuperValu Has Altered FCA Litigation
• Catching Up With Delaware's Chancery Court
• Trial Set In Ex-Ga. Insurance Chief's Fraud, Kickbacks Case
• PharMerica Unit Hit With Data Breach Class Action In Calif.
• Reed Smith VC Chair Joins Dentons' Tech Practice In Calif.
• Catholic Clinic Wants Colo. Abortion 'Reversal' Ban Blocked
• SEC Says CBD Exec Defrauded Hospital Of $13M During COVID
• Participating In Living History Makes Me A Better Lawyer
• Envision Inks $177M Deal In Billing Practices Securities Suit
• Drug Co. Again Seeks Toss Of $950M Vax Trade Secrets Case
• Bid To Nix ICE Doc's Subpoena Of Detainees' Lawyer Punted
• 11th Circ. Not Convinced $2.67B Blue Cross Deal Was Bad
• Mo. Pain Doctors Will Pay $653K To End Lab Kickback Claims
• Alito Extends Freeze Of Ban On Biden Social Media Work
• Dueling Doctor Opinions Right For Jury Decision, Panel Finds
• Sandoz Can't Get New Trial After $39M Eyelash Serum IP Loss
• Boston Univ. Pushed Out Worker For 'Long COVID,' Suit Says
• How A Gov't Shutdown Would Affect Immigration Processing
• Smart Immigration Reform Can Improve Health Care Access
• Doc's Plea In NBA Fraud Case Would Leave 2 To Stand Trial
• Mich. Panel Says Oncology Co. Owes Taxes On Lab Supplies
• Estate Wants Full 10th Circ. To Review EMT Liability Claims
• Private Equity Owners Can Remedy Law Firms' Agency Issues
• Firm Fights Sanctions In Georgia-Pacific Unit's Bankruptcy
• DLA Piper Adds Regulatory, Gov't Affairs Partner In Miami
• Cos. Must Overhaul Data Privacy Approach To Avoid Lawsuits
• Monsanto's Track Record On PCB Warnings Debated At Trial
• CFPB Plans Take Aim At Medical Debt Reporting, Data Brokers
• $11M Medicare Fraud Investigation Cut Corners, Jury Hears
• Fla. Jury Hears Openings In 'Take Care Of Maya' Med Mal Case
• Calif. Sues 'Predatory' Clinics Over 'Abortion Pill Reversal'
• Pomerantz To Be Lead Counsel In Mallinckrodt Investor Suit
• Google Judge Questions Need For Health Tracking Injunction
• No Bias In Denying Trans Health Coverage, States Tell 4th Circ.
• Gilead Sciences Gets Initial OK On $247M HIV Antitrust Deal
• Ill. Justices Weigh Privacy Claim After Firm Touted $4M Verdict
• Nursing Home Can't Use Contract For Arbitration After Death
• Opioid MDL Special Master Fights Bias DQ For 'Email Mistake'
• La. Sued Again Over Changes To US Drug Discount Program
• Canadian Tribe Denied More Time To Appeal Purdue Injunction
• American Physician Partners Plots Quick Ch. 11 Wind Down
• Yale, Prof. To Pay $1.5M And Share Drug Royalties In FCA Deal
• Fla. Man Pleads Not Guilty In $10M PPE Reselling Fraud
• Drug Cabinet Finger Scans Are BIPA-Exempt, Ill. Justices Hear
• Pa. Nonprofit Says Ex-CFO's Whistleblower Suit Lacks NJ Ties
• Abbott Gets Partial Win In HIV Test Patent Feud With Novartis
• A Topic-Based Analysis Of FDA Responses To FOIA Requests
• Mich. Health System, Law Firm Escape Debt Collection Suit
• Hartford Unit Scores 11th Circ. Win In Opioid Coverage Row
• Mass. Appeals Court Faults Tufts OT Stance For Disabled RN
• Fla. Nurse Convicted In $200M Medicare False Billing Scheme
• DC Circ. Doubts PR Hospital's 'Successor Bar' Challenge
• FTC Accuses PE Firm Of Raising Anesthesia Prices In Texas
• Democratic Bill Would 'Empower' FTC On Artificial Intelligence
• Biden Admin's Mental Health Proposal May Not Be Enough
• Skadden Nabs $19M Fee For 4 Months' Work On Endo Ch. 11
• Mass. Judge Tosses Desktop Metal Securities Suit For Good
• Hospital's Lawsuit Against SEIU Heading To RI
• Pa. Staffing Agency Wants $1.2M From Nursing Home Cos.
• NY Medical Group Resolves Syrian Doctor's Bias Suit
• Tenn. AG Inks $44.5M Opioid Deal With Grocery Chain
• Monsanto's 'Safe Level' PCB Defense Contested At Wash. Trial
• $10M Verdict Against Intuitive Lowered To Just A Dollar
• States Tell Alito Social Media Work Ban Protects Free Speech
• States' Rights, Trans Protections To Collide At 4th Circ.
• Keeping Hospital Docs Secret Not Any Easier After Pa. Ruling
• Microsoft Created Hostile Workplace, Trans Ex-Worker Says
• NC Provider Indicted In COVID, Medicaid Fraud Schemes
• Sutter Health Owes $519M For Double-Billing, Trial Judge Told
• Stryker Appeals OsteoMed's Surgical Implant Patent Wins
• Mallinckrodt Gets Final OK For $250M Ch. 11 Financing
• Meta Sued Over Lifting Health Info From Non-Facebook Users
• Travel Nurse Cos. Slam Claims Of Bait-And-Switch Pay Offers
• UPMC Doesn't Want To Share Docs With Defendant In Limbo
• UnitedHealth Narrows ERISA Suit Alleging Overcharging
• Drug Cos. Don't Always Provide Required Discounts To Gov't
• House Bill Would Shield Psilocybin Legalization From DOJ
• Ill. Justices Mull Sending Suit Over Abbott Drug To Jury
• Medicaid Contractor Sues Colo. Over Uber Payment Denial
• Biden Admin Extends Comment Period On Mental Health Regs
• Ariz. COVID Liability Shield Found Unconstitutional
• Del. Justices Urged To Reverse AmerisourceBergen Dismissal
• Post & Schell Grows Pittsburgh Office With Health Care Atty
• Opiate MDL Special Master Faces DQ Bid Over 'Reply All' Goof
• Fed. Circ. Hands Win To Roche In Blood Drug Fight
• Juror's Lies Justify New Trial In Sex Abuse Suit, Panel Finds
• How To Protect Atty-Client Privilege While Using Generative AI
• Takeda Settles Gout Drug Antitrust Case Midtrial
• Mich. High Court Won't Revive Flint Water Prosecutions
• Arnold & Porter Opens Boston Office With Life Science Focus
• Humana Tries To Ax Walgreens' Claims Over Crowell & Moring
• Monsanto Docs Show It Knew PCB Risks, Wash. Jury Hears
• Eli Lilly Launches 10 Suits Over New Diabetes Drug
• Merck Chided By AARP, Democrats Over Drug Price Suit
• Wash. Appeals Court Remands Kronos Hack Payment Dispute
• New Jersey Shore Town Wants Pot Co.'s Zoning Suit Tossed
• Judge OKs Juul's $255M Deal, Bars AI Co.'s 'En Masse' Claims
• J&J Defends Texas Two-Step Talc Gambit To Lawmakers
• TTAB Gives Health Group Partial Win In Registration Fight
• 1st Circ. Sides With J&J Subsidiary In Lactaid False Ad Suit
• Pa. Clinic And Doc Had No Duty To Family Attacked By Teen
• Takeda Wants End To Gout Drug Antitrust Case Midtrial
• HIV Drug Case Against Gilead Threatens Medical Innovation
• Valeant Says 9th Circ.'s FCA Disclosure Ruling Went Too Far
• How New Lawyers Can Leverage Feedback For Growth
• IT Firm Says NJ Court Can't Hear Ex-Exec's Termination Suit
• NC Doc Fights 25-Year Sentence For Reusing Medical Devices
• NJ Pharmacy Execs Charged In $33M Medicare Fraud Scheme
• House GOP Concerned VA Not Meeting 'Duty' To 'Buy America'
• BCBS Affiliate Must Face Trimmed Wilderness Therapy Suit
• Chamber Tells 6th Circ. Worker-Silencing Ruling Goes Too Far
• Maine Hospitals Urge High Court To Deny Review Of Vax Suit
• NC Doctor Was Misled In $11M Medicare Fraud, Jury Told
• COVID Test Maker Lucira Gets OK For Ch. 11 Liquidation
• Fla. CBD Biz, Investor Can't Score Wins In Fraud Suit
• Boston Scientific To Buy MedTech Biz In $850M Cash Deal
• State Privacy Laws: Not As Comprehensive As You May Think
• Medical Firm UpHealth Files For Ch. 11 After $31M Judgment
• American Physician Partners Hits Ch. 11 After Shutting Down
• NYC Atty Admits To Bilking Clients, Laundering Fraud Funds
• Walgreens Slams Crowell 'Hail Mary' To Avoid Ethics Hearing
• Gov't Says Hospital Profited Via Kickbacks To Sober Homes
• Feds Take Tribal Reimbursement Question To High Court
• NC Health Care Fraud Deal Ends $1.4M Claim, 4th Circ. Rules
• EPA Whiffed Toxic Chemical Deadline, Nonprofits Claim
• Disbarred Colorado Atty Pleads Guilty In Investment Scheme
• Ex-Cigna Employee To Settle SEC's Insider Trading Claim
• Lab Says BCBS Unit Owes Millions For COVID-19 Test Claims
• Worker Seeks OK Of $1.6M Kronos Hack Underpayment Deal
• Catching Up With Delaware's Chancery Court
• Sanofi Slams Mylan's 'Mishmash' Of Claims Over Insulin
• ESG Around The World: Australia
• Insurer Escapes Coverage Bid In Wrongful Death Suit
• GOP Reps. Mull Subpoena Of VA Abortion Policy Details
• Vedder Price Adds Ex-Nixon Peabody Litigator In Chicago
• Okla. High Court Won't Hear Case Challenging Pot Fees
• Concerns For 510(k) Sponsors After FDA Proposes Major Shift
• High Court's New FCA Ruling Is Quickly Making Trials Likelier
• 4th Circ. Preview: Transgender Health Care On Docket
• Split Ill. Appellate Panel Affirms $49M Med Mal Win
• Judge Denies Veolia's Expert Challenge In Flint Case
• Teva Faces Massive Investor Suit Over Opioid Scandal Fallout
• UBH Patients Nab Class Status In Mental Health Coverage Suit
• Louisiana Lab Owner Gets 3 Years For Medicare Kickback Ploy
• Chamber Urges Court To Block Medicare Drug Price Program
• Bankrupt Envision Strikes Settlement To End Securities Suit
• Pot Regulators Urge Congress To Address Hemp Products
• Ex-NBA Player, Doc Take Losses Ahead Of Health Fraud Trial
• Texas Justices Revive Med Mal Suit Over Expert Report Issue
• GSK, P&G And Others Sued Over 'Ineffective Decongestants'
• Developers Are Testing Defenses In Generative AI Litigation
• Criminal Trial Won't Delay Nursing Homes' Unpaid Wage Suit
• Court Adopts Report Tossing COVID Lab Suit Against Cigna
• Address The Data Monopoly, Otherwise Tech Giants Control AI
• How Calif. Ruling Extends Worker Bias Liability To 3rd Parties
• UK Litigation Roundup: Here's What You Missed In London
• Conn. Justices Ponder Whistleblower's Dual-Forum Approach
• Alito Freezes Ban On Biden Admin's Social Media Work
• P&G And J&J Sold Useless Decongestants, Suit Says
• Meta Must Face DC's COVID Vaccine Misinformation Subpoena
• Vyera Floats Rights Offering To Fix Ch. 11 Plan Objections
• Patients, Denver Hospital Ink $6.5M Deal Over Dirty OR Claims
• Fed. Circ. Won't Touch Hypertension Drug Producer's Loss
• Pfizer, BioNTech Lob Counterclaims In MRNA Vax Tech Suit
• 9th Circ. Judge Says Wash. Vax Mandate Challenge Has 'Legs'
• Mich. Justices To Hear Progressive's Appeal In Coverage Spat
• Schedule III Could Raise Regs On Medical Pot, Report Says
• FTC Warns Drugmakers Against Listing Illegitimate Patents
• Man Gets 28 Months For Bribing Mich. Pot Licensing Official
• Abcam Founder Opposes Danaher Deal, Wants Board Gone
• Hospital Told To ID Author Of Anon. Report In Death Suit
• Info Exchanges Must Stay Inside Now-Invisible Antitrust Lines
• Deals Rumor Mill: EagleView Technologies, New Era, Alibaba
• Dental Co. Seller Countersues Buyer In Del. Over $312M Deal
• Myovant, Sumitomo Deal Hurt By Skadden Conflict, Suit Says
• Biopharm Firm Hit With 2nd Suit Alleging Unpaid Wages
• Ex-Pfizer Worker To Stand Trial In Paxlovid Insider Case
• AmeriLife Hires Ex-MetLife Compliance Executive
• Twitter Legal Fees Suit Offers Crash Course In Billing Ethics
• PE Firms Told To Turn Over Some Docs In Poaching Case
• Nurse Staffing Firm's Layoffs Violate WARN Act, Suit Says
• Product Liability Claims Rose Over 5 Years, Report Says
• Alexion Inks $125M Deal In Investors' Suit Over Sales Tactics
• CareFirst Data Breach Fight Whittled Down To Contract Claim
• Medicaid Agency's Immunity From Retaliation Claim Affirmed
• Biz Groups Urge CFPB To Not Go After Medical Credit Cards
• Farmers' Medical Billing Limits Broke Minn. Law, Judge Says
• Trial Opens In Case At Heart Of Netflix's 'Take Care Of Maya'
• News Outlets Say State's Brief Didn't Address Antitrust Issues
• Wash. Panel Won't Revive Parents' Premature Birth Suit
• Aetna, Optum Can't Challenge ERISA Class Cert. Ruling
• Shareholder Seeks Cigna Records On Claim Denial 'Algorithm'
• Ga. Panel Shuns Barring Unvaccinated From Malpractice Jury
• Ex-CEO On 'Different Planet' In Discovery Row, NC Court Told
• Hospital Says Severance Ruling Shows NLRB 'Politicization'
• Medical Device Cos. Fight To Toss Conn. Birth Control Suits
• Shkreli-Tied Pharma Co. Cleared For $650K Ch. 11 Sale
• Laws Based On Rapid Drug Tests Are Unscientific And Unfair
• Amgen-Horizon Deal May Signal FTC's Return To Bargaining
• Ringleader In $41M Opioid Scheme Sentenced To 20 Years
• Integra Downplayed FDA Factory Warnings, Investor Suit Says
• Hunton Grows M&A Team With Ex-Holland & Knight Atty In DC
• Dentists, Toothbrush Biz Look To Settle Fax Advertising Action
• NJ Doc Keeps Trial Win In Baby Low Blood Sugar Suit
• Calif. Lawmakers Pass Pioneering Carbon Disclosure Bill
• Girardi's Dementia Diagnosis By USC Doc Challenged By Feds
• Sorrento OK'd For Alternative $110M Ch. 11 Stock Sale
• Insurers Seek Toss Of Foam Co.'s Chemical Coverage Suit
• Pa. Hospital Must Produce Admin's Notes In Patient Death Suit
• Shareholders Seek To Oust Nursing Home Majority Owner
• Insurer Asks 1st Circ. To Uphold Toss Of Hospital's Virus Suit
• HHS Assails Merck's 'Misunderstandings' Of Drug Pricing Law
• Organizations Urge Texas Courts To Curb 'Judge Shopping'
• Women Denied Abortions Launch Complaints In 3 States
• Fed. Circ. Backs Apple's PTAB Wins In Masimo Patent War
• 5th Circ. Presses Illumina On Cancer Test Competition
• Opioid Sales Fell By Half After 2010, DEA Data Shows
• Prisoner, 3 Others Cop To $25M COVID Relief Fraud
• SEC Hits Health Care Co. And Owner With $2.7M Fraud Suit
• Lead-Covered Verizon Cables Put Workers At Risk, Suit Says
• Indian Co. Urges Fed. Circ. To Back Obviousness Of Oxy IP
• Wis. Hospital Not Liable In Informed Consent Med Mal Suit
• PREP Act Doesn't Nix Worker-Injury Suit, Ohio Panel Finds
• Avoid Telehealth Pitfalls In A Post-Pandemic Environment
• Nursing Students Seek $10.35M+ Over 'Devastating' Closure
• Ex-Ga. Insurance Chief Says His Fraud Trial Hinges On $42
• 6th Circ. Asks Ohio Justices To Settle $650M Opioid Question
• Geico Accuses Fla. Chiropractic Clinic Of $8M No-Fault Scam
• Companies Must Dig Up Old Laws To Stay Privacy-Compliant
• Minn. Catering Biz Owners Cop To $250M Child Meals Scheme
• Latham, Quinn Emanuel Pressed For Docs In Antitrust Case
• 4th Circ. Partially Revives ERISA Suit Over Heart Transplant
• InterMune Ex-CEO's Atty Pressed To Defend Legal Fees In Del.
• Pharma Cos. Say Twitter Terror Ruling Requires DC Circ. Redo
• 9th Circ. Judges Open To Reviving Ariz. Abortion Law Fight
• US, Vietnam Draw Closer On Semiconductor Supply Chain
• HCA Healthcare Sued In Fla. Over Data Breach Of 11M Patients
• Catching Up With Delaware's Chancery Court
• Ohio Panel Backs Bowling Green's Win On COVID-19 Rules
• 8th Circ. Remands Casino's Virus Suit Over Jurisdiction Issue
• Ex-UNC Health Worker's Age Bias Demotion Claim Tossed
• ABA's Money-Laundering Resolution Is A Balancing Act
• 8 Ways Life Sciences Cos. Can Adapt To The Social Media Era
• FTC Settlements Widen Efforts To Shield Health Data
• Pool Supply Co. Investors Say COVID Panic Inflated Sales
• Former NY Congressman Joins Boutique Firm Emery Celli
• Ex-Mass. Health Care Chief Joins Manatt In Boston
• NJ Health Systems Settle Emergency Room Contract Fight
• Doctor Wants J&J Unit's Libel Suit Over Talc Study Tossed
• NC Doc Must Pay Almost $6M After Reusing Nose Devices
• NJ Lab Says Alliant Owes Payment For COVID-19 Testing
• Feds Fight Texas Atty's Bid To Toss Kickback Conviction
• 5th Circ. Backs Limits On Biden Admin's Social Media Work
• J&J Talc Unit Questions Distress Need In Ch. 11 Appeal
• NC Supreme Court Snapshot: 'False' Ad Fight In Spotlight
• Fla. Justices Question Abortion's Inclusion In Privacy Right
• Facebook Health Tracking Privacy Suit Slashed For Now
• Intent Needed In Insurance Fraud Case, Mich. Judge Says
• Alaska Native Org. Seeks Confirmation Of Info-Sharing Ruling
• Ex-AstraZeneca Sales Rep Seeks Cert. In Age Bias Action
• NLRB Official Seeks Pay Raises For Nurses At Colo. Hospital
• EMTs, Transport Co. Settle Unpaid Overtime Suit
• Kaiser To Pay $49M Over Illegal Waste Disposals In Calif.
• HHS Proposes 'Historic' Rule Combating Disability Bias
• IHS To Allocate $703M For Tribal Sanitation And Construction
• Ohio Panel Says Embattled Surgeon Entitled To New Trial
• Defendant In Harvard Body Theft Case Pleads Guilty
• Recalled Lentil Crumbles Cost Woman Gallbladder, Suit Says
• Drug Treatment Center Hit With Retaliation Suit By Ex-Director
• Katz SPAC Sues Medical Imaging Co. To Close $151M Merger
• Fresenius Gets 13 Cases Trimmed From Dialysis MDL
• Justices Urged To Hear Fight Over Abortion Pill Restrictions
• DC Circ. Ponders NLRB Remedy In Rite Aid Benefits Row
• Former DOJ Atty Joins Duane Morris White Collar Team In DC
• Ex-Nurse Hits Ga. Pediatrician With Unpaid Wages Suit
• Taxation With Representation: Wachtell, Kirkland, Latham
• UK Litigation Roundup: Here's What You Missed In London
• Kroger To Pay Up To $1.4B To End Opioid Claims
• 5th Circ. Clears Physician Over Taking Patient Off Life Support
• Pot Co. Owner Says Judge's Sanctions Are 'Blatantly Illegal'
• Biotech Fired Remote Exec Who Declined Vax, Suit Says
• Astellas Drops Suit Over Medicare Drug Price Negotiation Law
• Conn. Hearing Aid Dealer Sentenced To Prison In $6M Fraud
• Walgreens Cuts $44M Deal To End Theranos Consumer Suits
• 9th Circ. Backs Aetna In COVID Test Reimbursements Dispute
• Law Firm Professional Development Steps To Thrive In AI Era
• 10th Circ. Finds EMTs Immune In Suit Over Man's Death
• Consumer Group Backs Ga. Doctor's Appeal In Roundup Suit
• Calif. Panel Denies Arbitration In Nursing Home Death Suit
• DOJ Finds Unconstitutional COVID Care At NJ Vet Homes
• Conn. Doctor Used Own Sperm For Inseminations, Suit Says
• HHS Neuromonitoring Advisory May Have Broad Relevance
• Deals Rumor Mill: Great Wall Motor, Carlyle, Amer Sports
• 9th Circ.'s Latest UBH Ruling Ignores Case's Core Issue
• Philips Inks $479M Economic Losses Deal In CPAP Recall MDL
• Actelion Ducks RICO Suit Over Hypertension Drugs, For Now
• 4th Circ. Revives TCPA Suit Over Unsolicited Free E-Book Fax
• Altria's $45M Deal With Vapers Over Unsafe E-Cigs Wins OK
• Ohio Court OKs Doctor's Trial Win In Liposuction Death Suit
• 11th Circ. Says Trump Pardonee Can't Get Restitution Refund
• Ga. Panel Says Experts Rightly Excluded In Malaria Death Suit
• Pomerantz Seeks To Lead Mallinckrodt Investor Suit
• 'Tone It Down,' UnitedHealth Unit, No-Poach Plaintiffs Told
• Mass. AG Certifies 2 Psychedelics Legalization Efforts
• FTC-Amgen Deal: 'Major Advance,' Or 'Narrow Assurance'?
• Ga. Judge Pauses Block Of Ban On Trans Youths' Health Care
• Dermatologist No Substitute As Expert Witness, Panel Finds
• Wholesalers Tell Pa. Jury Takeda Delayed Generic Gout Drug
• Official Scraps NYC's $432M No-Bid Migrant Services Deal
• Docs, Orthopedic Group Reach Settlement Over Noncompetes
• Latham, Goodwin Rep On Thoma Bravo's $1.6B NextGen Buy
• No Ch. 11 Trustee For Prison Medical Co., Texas Judge Rules
• Eli Lilly Hit With Wrongful Death Suit Over Testosterone Drug
• TM Suit Doesn't Belong In Michigan, Judge Says
• Chancery Upholds AbbVie Damages In Takeda-Lupron Suit
• Wash. Appeals Panel Eyes Timeline In Stroke Malpractice Suit
• Veolia Tries To Halt Discovery Into PR Plan In Flint Water Case
• LA County Says Pharmacy Benefit Cos. Fueled Opioid Crisis
• 6th Circ. Partially Revives Ambulance Co.'s Suit Against Ky.
• Chancery Finds Drug Exec Breached Pact With Sorrento
• Investor Applauds As Health, Office REITs Call Off Merger
• Potential Marijuana Status Change Would Shift Industry Risks
• A New Strategy For Defending Spine Injury Claims
• Scientist Says Biopharma Firm Withholding Wages
• Unilever Sued Over Injury From Recalled Laundress Product
• Catching Up With Delaware's Chancery Court
• Novartis Joins Legal Fray After Price Negotiation List Unveiled
• Fla. Transgender Law Shows 'Moral Disapproval,' Court Told
• Hearing Aid Investors Lose 2nd Bid At Suit Over DOJ Probe
• Ga. Asks Court To Rethink Block On State's Trans Health Ban
• VA Finalizes Lowered Bar For Some Gulf War Vets' Benefits
• September Brings 5 Appellate Benefits Arguments To Watch
• NC Justices Give Software Maker 2nd Shot At Contract Claims
• Merger Proposals Reflect Agency Leaders' Antitrust Principles
• 11th Circ. OKs VA's Jury Win In Nurse's Union Retaliation Suit
• Senior Home Operator To Pay $4.25M In FCA Kickback Case
• Biden Pot Reform Effort Puts DEA In Hot Seat
• Surgeons Still In UPMC Suit As Purported Settlement Weighed
• Insurer Must Cover Mich. Town's Benefits Breach, Panel Says
• Ill. Hospital Sued For Seeking Workers' Family Medical History
• Atty Tells 9th Circ. Valeant Ruling Saves Allergan Patent Suit
• Mich. Parents Seek $423K Atty Fees, Costs For Infant Data Win
• For Radiation Oncology Units, Cyber Vigilance Is Crucial
• Massachusetts Man Makes Deal In N95 Price-Gouging Scheme
• Amgen Gets FTC Green Light On $28B Horizon Deal